Association of Type of Anesthetic and Outcomes in Transfemoral Aortic Valve Replacement

• Status: Unknown status
• Trial end date: 2021-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study proposes to perform a descriptive analysis and pilot observational study looking at the types and quantity of anesthetic agents used and their associations with outcomes among patients scheduled to receive transfemoral aortic valve replacements (TAVR) at Yale New Haven Hospital (YNHH).

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yale University
• Treatments: Anesthetics; Dexmedetomidine; Fentanyl; Midazolam; Propofol

Criteria

Inclusion Criteria:

• Patients who underwent TAVR at YNHH under planned conscious sedation with monitored anesthetic care

Exclusion Criteria:

• Patients who received monitored anesthesia care without the receipt of any study intervention drug (propofol, fentanyl, midazolam, or dexmedetomidine).